Contributed by: Dr. Tamhankar & Siddarth David
In the heel of the of 68th Session of the WHO's South East Asia Regional Committee in Dili, Timor-Leste, India would be issuing guidelines to restrict the blatant sale of antibiotics to avoid development of resistance. This is part of the global strategy adopted by the WHO member countries to control antibiotic resistance in diseases,
Rajesh Bhatia, chief scientific advisor to WHO Regional Director for South East Asia said that India was ready with guidelines for curbing the unrestricted sale of antibiotics in the country and would issue them soon. The WHO's South East Asia Regional Committee is meeting to discuss among other things the progress of the 11 member states in implementing national antibiotic control action plans by May 2017, a resolution taken the World Health Assembly in May this year at Geneva.
